Uncommon variants of mature T-cell lymphomas (MTCLs): Imaging and histopathologic and clinical features with updates from the fourth edition of the world health organization (WHO) classification of lymphoid neoplasms

Ahmed Ebada Salem, Yehia H. Zaki, Gamal El-Hussieny, Khaled I. ElNoueam, Akram M. Shaaban, Bhasker Rao Koppula, Ming Yang, Mohamed Salama, Khaled M. Elsayes, Matthew F. Covington

Research output: Contribution to journalArticlepeer-review

Abstract

Understanding the pathogenesis and molecular biology of malignant lymphomas is challenging, given the complex nature and incongruity of these disorders. The classification of lymphoma is continually evolving to account for advances in clinical, pathological, molecular biology and cytogenetic aspects, which impact our understanding of these disorders. The latest fourth edition of the WHO classification of lymphoid malignancies was released in 2016 to account for these changes. Additionally, unlike B-cell lymphomas (BCL), T-cell lymphomas (TCL) are uncommon, and may be sporadically experienced in clinical practice. These disorders are rare, thus early diagnosis is challenging for both physicians and radiologists, owing to the overlap in clinical and imaging features with other, more common disorders. We aim to discuss some rare variants of T-cell lymphomas, including clinicopathologic and imaging features, as well as to give a glimpse of the updates contained within the new 2016 WHO classification.

Original languageEnglish (US)
Article number5217
JournalCancers
Volume13
Issue number20
DOIs
StatePublished - Oct 1 2021

Keywords

  • 2016 WHO classification of hematologic malignancies
  • FDG-PET/CT
  • Imaging
  • Mature-T-cell lymphoma
  • Updates

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Uncommon variants of mature T-cell lymphomas (MTCLs): Imaging and histopathologic and clinical features with updates from the fourth edition of the world health organization (WHO) classification of lymphoid neoplasms'. Together they form a unique fingerprint.

Cite this